Aakriti Bhola

Currently managing performance of 6 team members (4 Senior Associates, 2 Associates), reporting directly to the Director,
owning hypothesis formulation across the deal continuumfor Fortune 500 clients in telecom, industrial products, healthcare,
and FMCG.
• Mergers & Acquisitions: Executed sign-to-close and post-close engagement on a global conglomerates $10.5B
carve-out, drafting TSA items, costing TSA scope, identifying RIDDs and entanglements, and stabilising payroll and
benefits for Day 1 continuity.
• Strategy & Corporate Development: Shaped the Day 1 operating model and target end-state architecture for a $4.4B
telecom acquisition, defining functional designs, decision rights, and synergy theses that informed the corporate
development roadmap and underpinned the value-creation business plan.
• Business Transformation & PMO Leadership: Governed 20+ functional workstreams on a $4.4B telecom integration
through a structured PMO, instituting weekly steering cadence, RAID logs, and Excel-based synergy tracking dashboards
that surfaced $200M in run-rate uplift and held workstream leads accountable to Day 1 milestones.
• Financial and Commercial Analysis: Conducted buy-side and sell-side standalone analyses, modelling HC, non-HC
expenses, and one-time costs from front and back-office functions, surfacing $165M in cost synergies through supply
chain and operations optimisation.

Led 2 Senior Analysts on healthcare and life sciences strategy mandates, reporting to Senior Manager, owning multi-project
delivery on M&A target identification, commercial due diligence, and growth strategyfor global life sciences clients.
• Mergers & Acquisitions: Delivered M&A target identification and commercial due diligence mandates for PE firms
investing in the healthcare space, supporting one $2B+ asset acquisition by a leading PE investor through screening and
validation analysis.
• Strategy & Corporate Development: Built outside-in market assessments and growth strategy points-of-view on Home
Healthcare, Digital Health, and US Healthcare Distribution, equipping global life sciences clients with sector entry
hypotheses and competitive positioning frameworks.
• Business Transformation & PMO Leadership: Ran the PMO across parallel life sciences mandates, instituting
workstream governance, allocating staffing and scope, sequencing deliverables from scoping through final client
presentation, and steering reporting cadence with global engagement teams to keep multi-project execution on track.
• Financial and Commercial Analysis Performed feasibility studies, market sizing, and strategic, commercial, and
operational due diligence for healthcare M&A targets, applying Capital-IQ, IBIS, and Euromonitor to benchmark
performance and surface acquisition rationale for PE investors.

Managedjunior associates on M&A and divestiture engagements, reporting to the Associate Director, owning commercial
due diligence and standalone analysis across software services, healthcare and life sciences, and consumer retail sectors.
• Mergers & Acquisitions: Drove target screening, commercial due diligence, and standalone analysis on 50+ M&A,
divestiture, and carve-out engagements across software services, healthcare, and consumer retail, surfacing acquisition
rationale and risk insights for buy-side and sell-side clients.
• Strategy & Corporate Development: Built market sizing, competitive positioning, and growth strategy points-of-view to
inform new market entry hypotheses and corporate development roadmaps for global PE and corporate clients,
sharpening deal selection criteria across diverse sectors and geographies.
• Business Transformation & PMO Leadership: Coordinated the PMO across concurrent M&A engagements, governing
junior associate workstreams, allocating scope, instituting review cadence on analytical outputs, and stewarding
deliverables from secondary research through final client storyboards under tight deal timelines.
• Financial and Commercial Analysis: Performed financial statement analysis, benchmarking, CIM construction, industry
KPI mapping, and company deep-dives using Capital-IQ, SNL, Merger market, and Thomson ONE, generating insights
that anchored 50+ DD and carve-out workstreams.